Skip to main content
TipRanks
Go Ultimate75% OFF

BioStem Technologies (BSEM) Financial Statements

315 Followers

BioStem Technologies Financial Overview

BioStem Technologies's market cap is currently $20.14M. The company's EPS TTM is $-2.35; its P/E ratio is -0.45; BioStem Technologies is estimated to report earnings on April 5, 2027, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 47.48M$ 301.83M$ 16.69M$ 6.88M$ 4.34M
Gross Profit$ 44.22M$ 288.08M$ 15.42M$ 5.99M$ 2.87M
Operating Income$ -689.15K$ 31.20M$ -7.78M$ -4.68M$ -1.61M
EBITDA$ -308.13K$ 31.49M$ -7.55M$ -6.54M$ -602.11K
Net Income$ -6.58M$ 31.88M$ -8.48M$ -7.19M$ -1.45M
Balance Sheet
Cash & Short-Term Investments$ 29.55M$ 22.83M$ 239.41K$ 772.14K$ 340.33K
Total Assets$ 50.03M$ 140.38M$ 14.56M$ 3.47M$ 2.67M
Total Debt$ 3.33M$ 4.39M$ 4.72M$ 5.09M$ 4.83M
Net Debt$ -26.22M$ -18.44M$ 4.48M$ 4.32M$ 4.49M
Total Liabilities$ 10.89M$ 99.50M$ 15.90M$ 7.42M$ 8.47M
Stockholders' Equity$ 39.14M$ 40.88M$ -1.34M$ -4.08M$ -5.96M
Cash Flow
Free Cash Flow$ 6.59M$ 24.05M$ -3.71M$ -165.91K$ -152.29K
Operating Cash Flow$ 9.94M$ 24.48M$ -3.50M$ 303.57K$ -109.44K
Investing Cash Flow$ -2.10M$ -1.68M$ -210.33K$ -469.48K$ -7.85K
Financing Cash Flow$ -1.12M$ -206.78K$ 3.18M$ 597.71K$ 357.42K

Currency in USD

BioStem Technologies Earnings and Revenue History

-200M0200M400M-1600 %-800 %0 %800 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

BioStem Technologies Liabilities to Assets

050M100M150M0 %120 %240 %360 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

BioStem Technologies Cash Flow

-10M-5M05M10M15M20M25M30M201720182019202020212022202320242025OperatingInvestingFinancing

BioStem Technologies Forecast EPS vs Actual EPS

-0.8-0.6-0.4-0.200.2Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss